Bio Eclipse Therapeutics
Biotechnology, 329 Oyster Point BLVD Fl 3, Mountain View, California, 94080, United States, 1-10 Employees
Phone Number: 40********
Who is BIOECLIPSE THERAPEUTICS
BioEclipse TherapeuticsTM is a clinical-stage oncology company that uses its proprietary technology to develop the next generation of immuno-oncology therapeutics. Foundationally, we have...
Read More
-
Headquarters: 329 Oyster Point BLVD Fl 3, Mountain View, California, 94080, United States
-
Date Founded: 2017
-
Employees: 1-10
-
Revenue: $1 Million to $5 Million
-
Active Tech Stack: See technologies
Industry: Biotechnology
SIC Code: 8731
Does something look wrong? Fix it. | View contact records from BIOECLIPSE THERAPEUTICS
BioEclipse Therapeutics Org Chart and Mapping
Email
Phone
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding BioEclipse Therapeutics
Answer: BioEclipse Therapeutics's headquarters are located at 329 Oyster Point BLVD Fl 3, Mountain View, California, 94080, United States
Answer: BioEclipse Therapeutics's phone number is 40********
Answer: BioEclipse Therapeutics's official website is https://bioeclipse.com
Answer: BioEclipse Therapeutics's revenue is $1 Million to $5 Million
Answer: BioEclipse Therapeutics's SIC: 8731
Answer: BioEclipse Therapeutics has 1-10 employees
Answer: BioEclipse Therapeutics is in Biotechnology
Answer: BioEclipse Therapeutics contact info: Phone number: 40******** Website: https://bioeclipse.com
Answer: BioEclipse TherapeuticsTM is a clinical-stage oncology company that uses its proprietary technology to develop the next generation of immuno-oncology therapeutics. Foundationally, we have harnessed a refined understanding of the human immune system, gaining insights into the reasons the bodys defense system so often turns a blind eye to the presence of cancerous cells and tumors. In response, BioEclipse TherapeuticsTM pairs activated immune cells with an adapted oncolytic virus that selectively infects and kills malignant cells. The result of this combination is a multi-mechanistic, targeted treatment that we believe will not only eradicate cancer cells, but also protect the patient from relapse and recurrence, through a durable immune response that prevents the development of new cancers, even in the face of new challenges from disease.
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month